Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications.

MLA

Hiwase, Devendra K., et al. “Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 14, no. 12, June 2008, pp. 3881–88. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-07-5095.

APA

Hiwase, D. K., Saunders, V., Hewett, D., Frede, A., Zrim, S., Dang, P., Eadie, L., To, L. B., Melo, J., Kumar, S., Hughes, T. P., & White, D. L. (2008). Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(12), 3881–3888. https://doi.org/10.1158/1078-0432.CCR-07-5095

Chicago

Hiwase, Devendra K, Verity Saunders, Duncan Hewett, Amity Frede, Stephanie Zrim, Phuong Dang, Laura Eadie, et al. 2008. “Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 14 (12): 3881–88. doi:10.1158/1078-0432.CCR-07-5095.